290 related articles for article (PubMed ID: 12083997)
1. Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder.
Pearlstein T; Yonkers KA
Expert Opin Pharmacother; 2002 Jul; 3(7):979-91. PubMed ID: 12083997
[TBL] [Abstract][Full Text] [Related]
2. Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.
Freeman EW
CNS Drugs; 2004; 18(7):453-68. PubMed ID: 15139800
[TBL] [Abstract][Full Text] [Related]
3. The role of fluoxetine in the treatment of premenstrual dysphoric disorder.
Romano S; Judge R; Dillon J; Shuler C; Sundell K
Clin Ther; 1999 Apr; 21(4):615-33; discussion 613. PubMed ID: 10363729
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors for premenstrual syndrome.
Marjoribanks J; Brown J; O'Brien PM; Wyatt K
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
[TBL] [Abstract][Full Text] [Related]
5. [Premenstrual dysphoric disorder (PMDD): Drug and psychotherapeutique management, a literature review].
Marais-Thomas H; Chapelle F; de Vaux-Boitouzet V; Bouvet C
Encephale; 2024 Apr; 50(2):211-232. PubMed ID: 37821319
[TBL] [Abstract][Full Text] [Related]
6. SSRIs for premenstrual dysphoric disorder.
Drug Ther Bull; 2002 Sep; 40(9):70-2. PubMed ID: 12298224
[TBL] [Abstract][Full Text] [Related]
7. Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.
Luisi AF; Pawasauskas JE
Pharmacotherapy; 2003 Sep; 23(9):1131-40. PubMed ID: 14524645
[TBL] [Abstract][Full Text] [Related]
8. Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline.
Halbreich U; Kahn LS
Expert Opin Pharmacother; 2003 Nov; 4(11):2065-78. PubMed ID: 14596660
[TBL] [Abstract][Full Text] [Related]
9. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.
Cohen LS; Miner C; Brown EW; Freeman E; Halbreich U; Sundell K; McCray S
Obstet Gynecol; 2002 Sep; 100(3):435-44. PubMed ID: 12220761
[TBL] [Abstract][Full Text] [Related]
10. Rapid response to fluoxetine in women with premenstrual dysphoric disorder.
Steinberg EM; Cardoso GM; Martinez PE; Rubinow DR; Schmidt PJ
Depress Anxiety; 2012 Jun; 29(6):531-40. PubMed ID: 22565858
[TBL] [Abstract][Full Text] [Related]
11. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria.
Steiner M; Korzekwa M; Lamont J; Wilkins A
Psychopharmacol Bull; 1997; 33(4):771-4. PubMed ID: 9493491
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine in the treatment of premenstrual dysphoric disorder.
Carr RR; Ensom MH
Ann Pharmacother; 2002 Apr; 36(4):713-7. PubMed ID: 11918525
[TBL] [Abstract][Full Text] [Related]
13. Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety.
Macdougall M; Steiner M
Expert Opin Drug Saf; 2003 Mar; 2(2):161-6. PubMed ID: 12904116
[TBL] [Abstract][Full Text] [Related]
14. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.
Miner C; Brown E; McCray S; Gonzales J; Wohlreich M
Clin Ther; 2002 Mar; 24(3):417-33. PubMed ID: 11952025
[TBL] [Abstract][Full Text] [Related]
15. Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature.
Silber TJ; Valadez-Meltzer A
J Adolesc Health; 2005 Dec; 37(6):518-25. PubMed ID: 16310133
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?
Pearlstein T
Drugs; 2002; 62(13):1869-85. PubMed ID: 12215058
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder.
Steiner M; Brown E; Trzepacz P; Dillon J; Berger C; Carter D; Reid R; Stewart D
Arch Womens Ment Health; 2003 Feb; 6(1):71-7. PubMed ID: 12715267
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
Shah NR; Jones JB; Aperi J; Shemtov R; Karne A; Borenstein J
Obstet Gynecol; 2008 May; 111(5):1175-82. PubMed ID: 18448752
[TBL] [Abstract][Full Text] [Related]
19. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
Yonkers KA; Pearlstein T; Fayyad R; Gillespie JA
J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
[TBL] [Abstract][Full Text] [Related]
20. [Sertraline in the treatment of premenstrual dysphoric disorder].
Culav-Sumić J; Skocilić Z; Jukić V
Lijec Vjesn; 1999; 121(7-8):234-8. PubMed ID: 10573958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
